End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
244,500 KRW | -2.59% |
|
-4.12% | -21.38% |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- With regards to fundamentals, the enterprise value to sales ratio is at 508.13 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.38% | 19.4B | - | ||
-1.55% | 37.97B | B- | ||
-23.99% | 11.83B | B- | ||
-2.73% | 10.33B | A- | ||
-15.89% | 9.46B | B+ | ||
+29.09% | 8.91B | C+ | ||
-8.08% | 5.72B | C+ | ||
-39.11% | 4.61B | C | ||
-24.93% | 3.52B | B+ | ||
-26.48% | 2.9B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- A051910 Stock
- A051915 Stock
- Ratings LG Chem, Ltd.